• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.09% Nasdaq Up 0.07%

    Opexa Therapeutics, Inc. (OPXA)

    -NasdaqCM
    0.39 Up 0.01(2.47%) May 21 - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:0.39
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:4.00
    Beta:2.49
    Earnings Date:Aug 12 - Aug 17 (Est.)
    Day's Range:0.38 - 0.42
    52wk Range:0.33 - 1.75
    Volume:444,258
    Avg Vol (3m):559,022
    Market Cap:10.99M
    P/E (ttm):N/A
    EPS (ttm):-0.54
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for OPXA

    Comparison

    Symbol% ChgMkt Cap
    OPXAUp 2.47%10.99M
    SNYDown 0.59%133.23B
    TEVADown 0.49%51.83B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):8.64
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.51
    Quarterly EPS Est (Jun-15) :-0.13
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized immunotherapy to treat multiple sclerosis (MS) and other autoimmune diseases, such as neuromyelitis optica (NMO) based on its proprietary T-cell technology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback